| Joshua Trull, | |
|
2500 N State St, Jackson, MS 39216-4500 | |
| (601) 815-1362 | |
| Not Available |
| Full Name | Joshua Trull |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 2500 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316400633 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | T-3891 (Mississippi) | Primary |
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
Agfa HealthCare announced today that Massachusetts General Hospital (MGH), a teaching hospital affiliated with Harvard Medical School located in Boston Mass., installed several of Agfa HealthCare's direct radiography (DR) technologies to update their inpatient and outpatient facilities. The eight DX-D 100 mobile DR systems and eight DX-D 600 fully automated DR rooms replace previous technologies.
Therapure Biomanufacturing, an integrated contract development and manufacturing organization and a division of Therapure Biopharma Inc., today announced approval for the manufacturing of Insmed Incorporated's ARIKAYCE® at its Mississauga facility by the U.S. Food and Drug Administration.
Prenatal exposure to nicotine could manifest as attention deficit hyperactivity disorder in children born a generation later, according to a new study by Florida State University College of Medicine researchers.
Sun Capital Partners, Inc., a leading private investment firm specializing in leveraged buyouts and investments in market-leading companies, today announced that an affiliate has acquired CornerStone Research & Development, Inc., a leading global contract manufacturer of top-branded vitamins and dietary supplements, from Mitsui & Co. (U.S.A.), Inc.
A specific biophysical model for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shows how potential drugs inhibiting both viral transcription and translation would be particularly effective against coronavirus disease (COVID-19). The model was developed by University of Minnesota researchers and described in their recent publication available on the bioRxiv preprint server.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Trull, 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 815-1362 | Joshua Trull, 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 815-1362 |
News Archive
Agfa HealthCare announced today that Massachusetts General Hospital (MGH), a teaching hospital affiliated with Harvard Medical School located in Boston Mass., installed several of Agfa HealthCare's direct radiography (DR) technologies to update their inpatient and outpatient facilities. The eight DX-D 100 mobile DR systems and eight DX-D 600 fully automated DR rooms replace previous technologies.
Therapure Biomanufacturing, an integrated contract development and manufacturing organization and a division of Therapure Biopharma Inc., today announced approval for the manufacturing of Insmed Incorporated's ARIKAYCE® at its Mississauga facility by the U.S. Food and Drug Administration.
Prenatal exposure to nicotine could manifest as attention deficit hyperactivity disorder in children born a generation later, according to a new study by Florida State University College of Medicine researchers.
Sun Capital Partners, Inc., a leading private investment firm specializing in leveraged buyouts and investments in market-leading companies, today announced that an affiliate has acquired CornerStone Research & Development, Inc., a leading global contract manufacturer of top-branded vitamins and dietary supplements, from Mitsui & Co. (U.S.A.), Inc.
A specific biophysical model for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shows how potential drugs inhibiting both viral transcription and translation would be particularly effective against coronavirus disease (COVID-19). The model was developed by University of Minnesota researchers and described in their recent publication available on the bioRxiv preprint server.
› Verified 5 days ago
Lamar Davis Ii, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5275 | |
Dr. Patrick E Weldon, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1860 Chadwick Drive, Suite 258, Jackson, MS 39204 Phone: 601-376-2004 Fax: 601-376-2006 | |
Derek Letort, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1200 N State St Ste 420, Jackson, MS 39202 Phone: 601-355-3353 Fax: 601-355-3365 | |
James Thompson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Ummc Department Of Pediatrics, Jackson, MS 39216 Phone: 601-984-5200 Fax: 601-984-2086 | |
Dr. Jahanzeb Khan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 Fax: 601-815-0434 | |
Dr. Kelsey Hillhouse Carr, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5514 | |
Dr. Tiffany Hoi-yan Pike-lee, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 330-808-8117 |